T de Boo
Overview
Explore the profile of T de Boo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
429
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lamfers E, Hooghoudt T, Schut A, de Boo T, Verheugt F
Neth Heart J
. 2015 Feb;
10(11):449-454.
PMID: 25696044
Background: Prehospital thrombolysis for acute ST-elevation myocardial infarction shortened treatment by 60 minutes, and created a large patient group who were treated within two hours. Objectives: We analysed our database...
2.
Sminkels O, Prins M, Veeniiuis R, de Boo T, Gerritsen M, van der Wilt G, et al.
Eur J Dermatol
. 2004 Jul;
14(3):159-65.
PMID: 15246941
The efficacy of UVB-phototherapy (UVB) and dithranol treatment for psoriasis is well established. However, well-conducted clinical trials on the efficacy of dithranol are not available, making comparison between these time-honoured...
3.
Netea M, Hijmans A, van Wissen S, Smilde T, Trip M, Kullberg B, et al.
Eur J Clin Invest
. 2004 Feb;
34(2):94-9.
PMID: 14764071
Background: Toll-like receptor-4 (TLR4) is a major receptor for inflammatory stimuli potentially involved in the pathogenesis of atherosclerosis, such as lipopolysaccharide (LPS) and heat-shock proteins. The Asp299Gly polymorphism of the...
4.
Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid
Swinkels O, Prins M, Kucharekova M, de Boo T, Gerritsen M, van der Valk P, et al.
Br J Dermatol
. 2002 Apr;
146(4):621-6.
PMID: 11966693
Background: Since its introduction, the effectiveness of dithranol in treating psoriasis has been unequalled by other topical treatments. Out-patient short-contact dithranol treatment is effective with regard to clinical response rate...
5.
Oerlemans H, Oostendorp R, de Boo T, Goris R
Clin Rehabil
. 2000 Jun;
14(3):331-9.
PMID: 10868729
Objective: To gain insight into the best way of obtaining an impairment rating in complex regional pain syndrome I (CRPS I) of the upper extremity. This syndrome can potentially result...
6.
van den Berkmortel F, Smilde T, Wollersheim H, van Langen H, de Boo T, Thien T
Atherosclerosis
. 2000 Jun;
150(2):397-401.
PMID: 10856532
Background And Purpose: Although it is known that smoking is associated with an increase in arterial wall thickness, most studies have been performed in heterogeneous groups of older age, already...
7.
Oerlemans H, Oostendorp R, de Boo T, van der Laan L, Severens J, Goris J
Arch Phys Med Rehabil
. 2000 Jan;
81(1):49-56.
PMID: 10638876
Objective: To investigate the effectiveness and cost of physical therapy (PT) or occupational therapy (OT) in patients with reflex sympathetic dystrophy (RSD). Design: Prospective randomized controlled trial, with 1 year...
8.
Oerlemans H, Graff M, de Boo T, Goris R, Oostendorp R
J Hand Ther
. 2000 Jan;
12(4):284-90.
PMID: 10622194
Recording asymmetry in skin temperature between symmetric body areas is useful in monitoring diseases that alter skin temperature. This pilot study checked the reported high reliability of recording skin temperature...
9.
Oerlemans H, Goris J, de Boo T, Oostendorp R
Am J Phys Med Rehabil
. 1999 Nov;
78(6):533-9.
PMID: 10574168
Reflex sympathetic dystrophy (RSD) is a disorder that can potentially result in permanent impairment. Because there are no adequate comparative studies regarding the additional value of physical therapy (PT) or...
10.
Oerlemans H, Oostendorp R, de Boo T, Perez R, Goris R
Clin J Pain
. 1999 Oct;
15(3):224-32.
PMID: 10524476
Objective: To assess the relation between the subjectively assessed and objectively measured diagnostic signs and symptoms in complex regional pain syndrome type I (CRPS I) and to quantify their severity....